Small molecule modulators of eukaryotic initiation factor 2α kinases, the key regulators of protein synthesis

Biochimie

Volumn 95, Issue 11, 2013, Pages 1980-1990

  Joshi, Manali ^a   Kulkarni, Abhijeet ^a   Pal, Jayanta K ^a  

^a UNIVERSITY OF PUNE   (India)

Author keywords

Activator; eIF 2 kinases; GCN2; HRI; Inhibitor; PERK; PKR

Indexed keywords

PROTEIN KINASE R;

ANEMIA; APOPTOSIS; CELL DIFFERENTIATION; CELL PROLIFERATION; DEGENERATIVE DISEASE; DEREGULATION; HUMAN; MAMMAL CELL; MODULATION; NEOPLASM; NONHUMAN; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; REVIEW; STRESS;

EUKARYOTA; MAMMALIA;

ACTIVATOR; EIF-2Α KINASES; GCN2; HRI; INHIBITOR; PERK; PKR;

EIF-2 KINASE; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; PHOSPHORYLATION; PROTEIN BIOSYNTHESIS; PROTEIN-SERINE-THREONINE KINASES; STRESS, PHYSIOLOGICAL;

EID: 84885070972     PISSN: 03009084     EISSN: 61831638     Source Type: Journal    
DOI: 10.1016/j.biochi.2013.07.030     Document Type: Short Survey

References (80)

1. T.D. Baird, and R.C. Wek Eukaryotic initiation factor 2 phosphorylation and translational control in metabolism Adv. Nutr. 2012 307 321
2. R.C. Wek, H.Y. Jiang, and T.G. Anthony Coping with stress: eIF2 kinases and translational control Biochem. Soc. Trans. 34 2006 7 11
3. N. Donnelly, A.M. Gorman, S. Gupta, and A. Samali The eIF2alpha kinases: their structures and functions Cell. Mol. Life Sci. 2013
4. M.J. Clemens Initiation factor eIF2 alpha phosphorylation in stress responses and apoptosis Prog. Mol. Subcell. Biol. 27 2001 57 89
5. F.L. Erickson, J. Nika, S. Rippel, and E.M. Hannig Minimum requirements for the function of eukaryotic translation initiation factor 2 Genetics 158 2001 123 132
6. S.R. Kimball Eukaryotic initiation factor eIF2 Int. J. Biochem. Cell Biol. 31 1999 25 29
7. M.J. Clemens Regulation of eukaryotic protein synthesis by protein kinases that phosphorylate initiation factor eIF-2 Mol. Biol. Rep. 19 1994 201 210
8. C.G. Proud eIF2 and the control of cell physiology Semin. Cell Dev. Biol. 16 2005 3 12
9. J.J. Chen Regulation of protein synthesis by the heme-regulated eIF2alpha kinase: relevance to anemias Blood 109 2007 2693 2699
10. A. Yerlikaya, S.R. Kimball, and B.A. Stanley Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase Biochem. J. 412 2008 579 588
11. A. Sarkar, A. Kulkarni, S. Chattopadhyay, D. Mogare, K.K. Sharma, K. Singh, and J.K. Pal Lead-induced upregulation of the heme-regulated eukaryotic initiation factor 2alpha kinase is compromised by hemin in human K562 cells Biochim. Biophys. Acta 1732 2005 15 22
12. S. Anand, and J.K. Pal The haem-regulated eukaryotic initiation factor 2alpha kinase: a molecular indicator of lead-toxicity anaemia in rabbits Biotechnol. Appl. Biochem. 36 2002 57 62
13. R.L. Matts, J.R. Schatz, R. Hurst, and R. Kagen Toxic heavy metal ions activate the heme-regulated eukaryotic initiation factor-2 alpha kinase by inhibiting the capacity of hemin-supplemented reticulocyte lysates to reduce disulfide bonds J. Biol. Chem. 266 1991 12695 12702
14. A.P. Kulkarni, S.P. Mittal, T.P. Devasagayam, and J.K. Pal Oxidative stress perturbs cell proliferation in human K562 cells by modulating protein synthesis and cell cycle Free Radic. Res. 43 2009 1090 1100
15. A.P. Kulkarni, S.P. Mittal, T.P. Devasagayam, and J.K. Pal Hsp90 mediates activation of the heme regulated eIF-2 alpha kinase during oxidative stress Indian J. Biochem. Biophys. 47 2010 67 74
16. L. Lu, A.P. Han, and J.J. Chen Translation initiation control by heme-regulated eukaryotic initiation factor 2alpha kinase in erythroid cells under cytoplasmic stresses Mol. Cell. Biol. 21 2001 7971 7980
17. A. Sarkar, S. Chattopadhyay, R. Kaul, and J.K. Pal Lead exposure and heat shock inhibit cell proliferation in human HeLa and K562 cells by inducing expression and activity of the heme-regulated eIF-2alpha kinase J. Biochem. Mol. Biol. Biophys. 6 2002 391 396
18. T. Nakamura, M. Furuhashi, P. Li, H. Cao, G. Tuncman, N. Sonenberg, C.Z. Gorgun, and G.S. Hotamisligil Double-stranded RNA-dependent protein kinase links pathogen sensing with stress and metabolic homeostasis Cell 140 2010 338 348
19. R. Onuki, Y. Bando, E. Suyama, T. Katayama, H. Kawasaki, T. Baba, M. Tohyama, and K. Taira An RNA-dependent protein kinase is involved in tunicamycin-induced apoptosis and Alzheimer's disease EMBO J. 23 2004 959 968
20. P.P. Ruvolo, F. Gao, W.L. Blalock, X. Deng, and W.S. May Ceramide regulates protein synthesis by a novel mechanism involving the cellular PKR activator RAX J. Biol. Chem. 276 2001 11754 11758
21. T. Ito, M. Yang, and W.S. May RAX, a cellular activator for double-stranded RNA-dependent protein kinase during stress signaling J. Biol. Chem. 274 1999 15427 15432
22. E. Szegezdi, S.E. Logue, A.M. Gorman, and A. Samali Mediators of endoplasmic reticulum stress-induced apoptosis EMBO Rep. 7 2006 880 885
23. H.P. Harding, Y. Zhang, H. Zeng, I. Novoa, P.D. Lu, M. Calfon, N. Sadri, C. Yun, B. Popko, R. Paules, D.F. Stojdl, J.C. Bell, T. Hettmann, J.M. Leiden, and D. Ron An integrated stress response regulates amino acid metabolism and resistance to oxidative stress Mol. Cell 11 2003 619 633
24. C. Deval, C. Chaveroux, A.C. Maurin, Y. Cherasse, L. Parry, V. Carraro, D. Milenkovic, M. Ferrara, A. Bruhat, C. Jousse, and P. Fafournoux Amino acid limitation regulates the expression of genes involved in several specific biological processes through GCN2-dependent and GCN2-independent pathways FEBS J. 276 2009 707 718
25. J.R. Murguia, and R. Serrano New functions of protein kinase Gcn2 in yeast and mammals IUBMB Life 64 2012 971 974
26. J. Ye, M. Kumanova, L.S. Hart, K. Sloane, H. Zhang, D.N. De Panis, E. Bobrovnikova-Marjon, J.A. Diehl, D. Ron, and C. Koumenis The GCN2-ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivation EMBO J. 29 2010 2082 2096
27. R. Yang, S.A. Wek, and R.C. Wek Glucose limitation induces GCN4 translation by activation of Gcn2 protein kinase Mol. Cell 20 2000 2706 2717
28. J.J. Berlanga, I. Ventoso, H.P. Harding, J. Deng, D. Ron, N. Sonenberg, L. Carrasco, and C. de Haro Antiviral effect of the mammalian translation initiation factor 2alpha kinase GCN2 against RNA viruses EMBO J. 25 2006 1730 1740
29. J. Krishnamoorthy, Z. Mounir, J.F. Raven, and A.E. Koromilas The eIF2alpha kinases inhibit vesicular stomatitis virus replication independently of eIF2alpha phosphorylation Cell Cycle 7 2008 2346 2351
30. B. Grallert, and E. Boye The Gcn2 kinase as a cell cycle regulator Cell Cycle 6 2007 2768 2772
31. M. Zamanian-Daryoush, T.H. Mogensen, J.A. DiDonato, and B.R. Williams NF-kappaB activation by double-stranded-RNA-activated protein kinase (PKR) is mediated through NF-kappaB-inducing kinase and IkappaB kinase Mol. Cell. Biol. 20 2000 1278 1290
32. S.B. Cullinan, D. Zhang, M. Hannink, E. Arvisais, R.J. Kaufman, and J.A. Diehl Nrf2 is a direct PERK substrate and effector of PERK-dependent cell survival Mol. Cell. Biol. 23 2003 7198 7209
33. E. McEwen, N. Kedersha, B. Song, D. Scheuner, N. Gilks, A. Han, J.J. Chen, P. Anderson, and R.J. Kaufman Heme-regulated inhibitor kinase-mediated phosphorylation of eukaryotic translation initiation factor 2 inhibits translation, induces stress granule formation, and mediates survival upon arsenite exposure J. Biol. Chem. 280 2005 16925 16933
34. A.P. Han, C. Yu, L. Lu, Y. Fujiwara, C. Browne, G. Chin, M. Fleming, P. Leboulch, S.H. Orkin, and J.J. Chen Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency EMBO J. 20 2001 6909 6918
35. S.H. Kim, S. Gunnery, J.K. Choe, and M.B. Mathews Neoplastic progression in melanoma and colon cancer is associated with increased expression and activity of the interferon-inducible protein kinase, PKR Oncogene 21 2002 8741 8748
36. S.H. Kim, A.P. Forman, M.B. Mathews, and S. Gunnery Human breast cancer cells contain elevated levels and activity of the protein kinase, PKR Oncogene 19 2000 3086 3094
37. Y.L. Yang, L.F. Reis, J. Pavlovic, A. Aguzzi, R. Schafer, A. Kumar, B.R. Williams, M. Aguet, and C. Weissmann Deficient signaling in mice devoid of double-stranded RNA-dependent protein kinase EMBO J. 14 1995 6095 6106
38. A. Pataer, S.G. Swisher, J.A. Roth, C.J. Logothetis, and P.G. Corn Inhibition of RNA-dependent protein kinase (PKR) leads to cancer cell death and increases chemosensitivity Cancer Biol. Ther. 8 2009 245 252
39. J.H. Lin, H. Li, D. Yasumura, H.R. Cohen, C. Zhang, B. Panning, K.M. Shokat, M.M. Lavail, and P. Walter IRE1 signaling affects cell fate during the unfolded protein response Science 318 2007 944 949
40. J.H. Lin, H. Li, Y. Zhang, D. Ron, and P. Walter Divergent effects of PERK and IRE1 signaling on cell viability PLoS ONE 4 2009 e4170
41. W. Zhang, D. Feng, Y. Li, K. Iida, B. McGrath, and D.R. Cavener PERK EIF2AK3 control of pancreatic beta cell differentiation and proliferation is required for postnatal glucose homeostasis Cell Metab. 4 2006 491 497
42. H.P. Harding, H. Zeng, Y. Zhang, R. Jungries, P. Chung, H. Plesken, D.D. Sabatini, and D. Ron Diabetes mellitus and exocrine pancreatic dysfunction in perk-/- mice reveals a role for translational control in secretory cell survival Mol. Cell 7 2001 1153 1163
43. B.C. Mak, Q. Wang, C. Laschinger, W. Lee, D. Ron, H.P. Harding, R.J. Kaufman, D. Scheuner, R.C. Austin, and C.A. McCulloch Novel function of PERK as a mediator of force-induced apoptosis J. Biol. Chem. 283 2008 23462 23472
44. F. Guo, and D.R. Cavener The GCN2 eIF2alpha kinase regulates fatty-acid homeostasis in the liver during deprivation of an essential amino acid Cell Metab. 5 2007 103 114
45. M. Costa-Mattioli, D. Gobert, H. Harding, B. Herdy, M. Azzi, M. Bruno, M. Bidinosti, C. Ben Mamou, E. Marcinkiewicz, M. Yoshida, H. Imataka, A.C. Cuello, N. Seidah, W. Sossin, J.C. Lacaille, D. Ron, K. Nader, and N. Sonenberg Translational control of hippocampal synaptic plasticity and memory by the eIF2alpha kinase GCN2 Nature 436 2005 1166 1173
46. M. Costa-Mattioli, D. Gobert, E. Stern, K. Gamache, R. Colina, C. Cuello, W. Sossin, R. Kaufman, J. Pelletier, K. Rosenblum, K. Krnjevic, J.C. Lacaille, K. Nader, and N. Sonenberg eIF2alpha phosphorylation bidirectionally regulates the switch from short- to long-term synaptic plasticity and memory Cell 129 2007 195 206
47. T.E. Dever, and A.G. Hinnebusch GCN2 whets the appetite for amino acids Mol. Cell 18 2005 141 142
48. S. Uma, B.G. Yun, and R.L. Matts The heme-regulated eukaryotic initiation factor 2alpha kinase. A potential regulatory target for control of protein synthesis by diffusible gases J. Biol. Chem. 276 2001 14875 14883
49. M. Miksanova, J. Igarashi, M. Minami, I. Sagami, S. Yamauchi, H. Kurokawa, and T. Shimizu Characterization of heme-regulated eIF2alpha kinase: roles of the N-terminal domain in the oligomeric state, heme binding, catalysis, and inhibition Biochemistry 45 2006 9894 9905
50. K.C. Kanelakis, J. Pyati, P.C. Wagaman, J.C. Chuang, Y. Yang, and N.P. Shankley Functional characterization of the canine heme-regulated eIF2alpha kinase: regulation of protein synthesis Adv. Hematol. 2009 2009 251915
51. M.D. Rosen, C.R. Woods, S.D. Goldberg, M.D. Hack, A.D. Bounds, Y. Yang, P.C. Wagaman, V.K. Phuong, A.P. Ameriks, T.D. Barrett, K.C. Kanelakis, J.C. Chuang, N.P. Shankley, and M.H. Rabinowitz Discovery of the first known small-molecule inhibitors of heme-regulated eukaryotic initiation factor 2alpha (HRI) kinase Bioorg. Med. Chem. Lett. 19 2009 6548 6551
52. T. Chen, D. Ozel, Y. Qiao, F. Harbinski, L. Chen, S. Denoyelle, X. He, N. Zvereva, J.G. Supko, M. Chorev, J.A. Halperin, and B.H. Aktas Chemical genetics identify eIF2alpha kinase heme-regulated inhibitor as an anticancer target Nat. Chem. Biol. 7 2011 610 616
53. K.M. Vattem, and R.C. Wek Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells Proc. Natl. Acad. Sci. U S A 101 2004 11269 11274
54. S. Denoyelle, T. Chen, L. Chen, Y. Wang, E. Klosi, J.A. Halperin, B.H. Aktas, and M. Chorev In vitro inhibition of translation initiation by N,N′'-diarylureas-potential anti-cancer agents Bioorg. Med. Chem. Lett. 22 2012 402 409
55. J.T. Huang, and R.J. Schneider Adenovirus inhibition of cellular protein synthesis is prevented by the drug 2-aminopurine Proc. Natl. Acad. Sci. U S A 87 1990 7115 7119
56. C. Brunelli, C. Amici, M. Angelini, C. Fracassi, G. Belardo, and M.G. Santoro The non-steroidal anti-inflammatory drug indomethacin activates the eIF2alpha kinase PKR, causing a translational block in human colorectal cancer cells Biochem. J. 443 2012 379 386
57. N.V. Jammi, L.R. Whitby, and P.A. Beal Small molecule inhibitors of the RNA-dependent protein kinase Biochem. Biophys. Res. Commun. 308 2003 50 57
58. H.L. Eley, and M.J. Tisdale Skeletal muscle atrophy, a link between depression of protein synthesis and increase in degradation J. Biol. Chem. 282 2007 7087 7097
59. H.L. Eley, S.T. Russell, and M.J. Tisdale Attenuation of muscle atrophy in a murine model of cachexia by inhibition of the dsRNA-dependent protein kinase Br. J. Cancer 96 2007 1216 1222
60. H.L. Eley, P.S. McDonald, S.T. Russell, and M.J. Tisdale Inhibition of activation of dsRNA-dependent protein kinase and tumour growth inhibition Cancer Chemother. Pharmacol. 63 2009 651 659
61. S. Ingrand, L. Barrier, C. Lafay-Chebassier, B. Fauconneau, G. Page, and J. Hugon The oxindole/imidazole derivative C16 reduces in vivo brain PKR activation FEBS Lett. 581 2007 4473 4478
62. R. Bryk, K. Wu, B.C. Raimundo, P.E. Boardman, P. Chao, G.L. Conn, E. Anderson, J.L. Cole, N.P. Duffy, C. Nathan, and J.H. Griffin Identification of new inhibitors of protein kinase R guided by statistical modeling Bioorg. Med. Chem. Lett. 21 2011 4108 4114
63. H. Han, and P.B. Dervan Sequence-specific recognition of double helical RNA and RNA.DNA by triple helix formation Proc. Natl. Acad. Sci. U S A 90 1993 3806 3810
64. R.W. Roberts, and D.M. Crothers Stability and properties of double and triple helices: dramatic effects of RNA or DNA backbone composition Science 258 1992 1463 1466
65. M. Vuyisich, and P.A. Beal Regulation of the RNA-dependent protein kinase by triple helix formation Nucleic Acids Res. 28 2000 2369 2374
66. D.P. Figgitt, W.A. Denny, S.A. Gamage, and R.K. Ralph Structure-activity relationships of 9-anilinoacridines as inhibitors of human DNA topoisomerase II Anticancer Drug Des 9 1994 199 208
67. C.B. Carlson, R.J. Spanggord, and P.A. Beal Selection of small-molecule mediators of the RNA regulation of PKR, the RNA-dependent protein kinase Chembiochem 3 2002 859 865
68. R.J. Spanggord, and P.A. Beal Selective binding by the RNA binding domain of PKR revealed by affinity cleavage Biochemistry 40 2001 4272 4280
69. D.T. Rutkowski, S.W. Kang, A.G. Goodman, J.L. Garrison, J. Taunton, M.G. Katze, R.J. Kaufman, and R.S. Hegde The role of p58IPK in protecting the stressed endoplasmic reticulum Mol. Biol. Cell. 18 2007 3681 3691
70. M. Bollo, R.M. Paredes, D. Holstein, N. Zheleznova, P. Camacho, and J.D. Lechleiter Calcineurin interacts with PERK and dephosphorylates calnexin to relieve ER stress in mammals and frogs PLoS ONE 5 2010 e11925
71. H.P. Harding, Y. Zhang, S. Khersonsky, S. Marciniak, D. Scheuner, R.J. Kaufman, N. Javitt, Y.T. Chang, and D. Ron Bioactive small molecules reveal antagonism between the integrated stress response and sterol-regulated gene expression Cell Metab. 2 2005 361 371
72. H. Wang, J. Blais, D. Ron, and T. Cardozo Structural determinants of PERK inhibitor potency and selectivity Chem. Biol. Drug Des. 76 2010 480 495
73. J.M. Axten, J.R. Medina, Y. Feng, A. Shu, S.P. Romeril, S.W. Grant, W.H. Li, D.A. Heerding, E. Minthorn, T. Mencken, C. Atkins, Q. Liu, S. Rabindran, R. Kumar, X. Hong, A. Goetz, T. Stanley, J.D. Taylor, S.D. Sigethy, G.H. Tomberlin, A.M. Hassell, K.M. Kahler, L.M. Shewchuk, and R.T. Gampe Discovery of 7-methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl) -7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a potent and selective first-in-class inhibitor of protein kinase R (PKR)-like endoplasmic reticulum kinase (PERK) J. Med. Chem. 55 2012 7193 7207
74. H.P. Harding, A.F. Zyryanova, and D. Ron Uncoupling proteostasis and development in vitro with a small molecule inhibitor of the pancreatic endoplasmic reticulum kinase, PERK J. Biol. Chem. 287 2012 44338 44344
75. J. Visweswaraiah, S. Lageix, B.A. Castilho, L. Izotova, T.G. Kinzy, A.G. Hinnebusch, and E. Sattlegger Evidence that eukaryotic translation elongation factor 1A (eEF1A) binds the Gcn2 protein C terminus and inhibits Gcn2 activity J. Biol. Chem. 286 2011 36568 36579
76. C.M. Pereira, E. Sattlegger, H.Y. Jiang, B.M. Longo, C.B. Jaqueta, A.G. Hinnebusch, R.C. Wek, L.E. Mello, and B.A. Castilho IMPACT, a protein preferentially expressed in the mouse brain, binds GCN1 and inhibits GCN2 activation J. Biol. Chem. 280 2005 28316 28323
77. F. Robert, C. Williams, Y. Yan, E. Donohue, R. Cencic, S.K. Burley, and J. Pelletier Blocking UV-induced eIF2alpha phosphorylation with small molecule inhibitors of GCN2 Chem. Biol. Drug Des. 74 2009 57 67
78. F. Meggio, A. Donella Deana, M. Ruzzene, A.M. Brunati, L. Cesaro, B. Guerra, T. Meyer, H. Mett, D. Fabbro, and P. Furet Different susceptibility of protein kinases to staurosporine inhibition. Kinetic studies and molecular bases for the resistance of protein kinase CK2 Eur. J. Biochem. 234 1995 317 322
79. G. Manning, D.B. Whyte, R. Martinez, T. Hunter, and S. Sudarsanam The protein kinase complement of the human genome Science 298 2002 1912 1934
80. Y. Liu, and N.S. Gray Rational design of inhibitors that bind to inactive kinase conformations Nat. Chem. Biol. 2 2006 358 364